Akesiss Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 16-06-2024
- Paid Up Capital ₹ 4.50 M
as on 16-06-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.99 Cr
as on 16-06-2024
- Satisfied Charges ₹ 1.83 Cr
as on 16-06-2024
- Revenue 3.96%
(FY 2023)
- Profit 22.33%
(FY 2023)
- Ebitda 17.88%
(FY 2023)
- Net Worth 32.17%
(FY 2023)
- Total Assets 27.04%
(FY 2023)
About Akesiss Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹3.99 Cr. The company has closed loans amounting to ₹1.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Narayan Biji, Thomsan George, Padmadas Panjajanyam, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232KL2008PTC023419
- Company No.
023419
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kochi, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Akesiss Pharma Private Limited offer?
Akesiss Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Antibacterial Drugs, Sexual Wellness Products, Fertility Enhancer, Cardiovascular Drugs & Medication, Diabetes Medicine, Anti Asthma Drug, Levocetirizine Hydrochloride Montelukast Sodium Tablet.
Who are the key members and board of directors at Akesiss Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Kannampalam  | Managing Director | 18-Nov-2008 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thomsan George | Whole-Time Director | 18-Nov-2008 | Current |
| Padmadas Panjajanyam | Whole-Time Director | 18-Nov-2008 | Current |
| Narayan Biji | Director | 01-Jan-2013 | Current |
| Sharatkumar Kumarakurup | Whole-Time Director | 18-Nov-2008 | Current |
Financial Performance of Akesiss Pharma.
Akesiss Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.96% increase. The company also saw a substantial improvement in profitability, with a 22.33% increase in profit. The company's net worth Soared by an impressive increase of 32.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akesiss Pharma?
In 2023, Akesiss Pharma had a promoter holding of 62.07% and a public holding of 37.93%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Megasys Biotek Private LimitedActive 19 years 10 monthsNarayan Biji, Thomsan George and 3 more are mutual person
Akesiss Healthcare LlpActive 5 years 5 monthsThomsan George, Padmadas Panjajanyam and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Jun 2023 | ₹7.20 M | Open |
Others Creation Date: 04 Nov 2022 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Jan 2022 | ₹0.70 M | Open |
How Many Employees Work at Akesiss Pharma?
Akesiss Pharma has a workforce of 251 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akesiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akesiss Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
